Suppr超能文献

用于血液透析的中心静脉导管的临床和监管注意事项。

Clinical and Regulatory Considerations for Central Venous Catheters for Hemodialysis.

机构信息

Center for Devices and Radiological Health, Division of Reproductive, Gastro-Renal, and Urological Devices, Renal Devices Branch, US Food and Drug Administration, Silver Spring, Maryland.

Interventional Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1924-1932. doi: 10.2215/CJN.14251217. Epub 2018 Oct 11.

Abstract

Central venous catheters remain a vital option for access for patients receiving maintenance hemodialysis. There are many important and evolving clinical and regulatory considerations for all stakeholders for these devices. Innovation and transparent and comprehensive regulatory review of these devices is essential to stimulate innovation to help promote better outcomes for patients receiving maintenance hemodialysis. A workgroup that included representatives from academia, industry, and the US Food and Drug Administration was convened to identify the major design considerations and clinical and regulatory challenges of central venous catheters for hemodialysis. Our intent is to foster improved understanding of these devices and provide the foundation for strategies to foster innovation of these devices.

摘要

中心静脉导管仍然是接受维持性血液透析患者的重要选择。对于这些设备的所有利益相关者,都有许多重要且不断发展的临床和监管方面的考虑因素。对这些设备进行创新和透明、全面的监管审查至关重要,这有助于激发创新,帮助接受维持性血液透析的患者获得更好的治疗效果。一个由学术界、工业界和美国食品和药物管理局代表组成的工作组被召集起来,以确定用于血液透析的中心静脉导管的主要设计考虑因素和临床及监管挑战。我们的目的是促进对这些设备的更好理解,并为促进这些设备创新的策略提供基础。

相似文献

2
FDA Regulatory Perspectives for Studies on Hemodialysis Vascular Access.FDA 对血液透析血管通路研究的监管观点。
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):513-518. doi: 10.2215/CJN.02900317. Epub 2017 Jul 24.
3
Hemodialysis catheters: which design is more cost-effective?血液透析导管:哪种设计更具成本效益?
Am J Kidney Dis. 2015 Jul;66(1):170. doi: 10.1053/j.ajkd.2014.04.040. Epub 2015 May 19.
4
Recommended Clinical Trial End Points for Dialysis Catheters.推荐的透析导管临床试验终点。
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):495-500. doi: 10.2215/CJN.12011116. Epub 2017 Jul 20.
7
Peripherally Inserted Central Catheters and Hemodialysis Outcomes.外周静脉穿刺中心静脉导管与血液透析结局
Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1434-1440. doi: 10.2215/CJN.01980216. Epub 2016 Jun 23.
8
Prevention of Bloodstream Infections in Patients Undergoing Hemodialysis.血液透析患者的血流感染预防。
Clin J Am Soc Nephrol. 2020 Jan 7;15(1):132-151. doi: 10.2215/CJN.06820619. Epub 2019 Dec 5.

引用本文的文献

7
The evolving panorama of vascular access in the 21st century.21世纪血管通路的发展全景。
Front Nephrol. 2022 Oct 26;2:917265. doi: 10.3389/fneph.2022.917265. eCollection 2022.

本文引用的文献

2
Methods for evaluating antimicrobial activity: A review.抗菌活性评估方法:综述
J Pharm Anal. 2016 Apr;6(2):71-79. doi: 10.1016/j.jpha.2015.11.005. Epub 2015 Dec 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验